Top Vaccines companies in Sweden by Operating Income

This ranking features the top 10 Vaccines companies in Sweden ranked by Operating Income, totaling a Operating Income of USD 427.26 M, for July 08, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Vaccines company in Sweden has the highest Operating Income ?

The Vaccines company in Sweden with the highest Operating Income is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 506.25 M.

Which Vaccines company in Sweden has the lowest Operating Income ?

The Vaccines company in Sweden with the lowest Operating Income is Cantargia AB (publ) (Stockholm Stock Exchange: CANTA.ST) at USD -15.17 M.

What are the top 10 Vaccines companies in Sweden by Operating Income ?

The top 10 Vaccines companies in Sweden by Operating Income are Swedish Orphan Biovitrum AB (publ), Alzinova AB (publ), Iconovo AB (publ), Enzymatica AB (publ), Intervacc AB (publ), SynAct Pharma AB, Mendus AB (publ), Infant Bacterial Therapeutics AB (publ), Diamyd Medical AB (publ) and Cantargia AB (publ).

What are the bottom 10 Vaccines companies in Sweden by Operating Income ?

The bottom 10 Vaccines companies in Sweden by Operating Income are Cantargia AB (publ), Diamyd Medical AB (publ), Infant Bacterial Therapeutics AB (publ), Mendus AB (publ), SynAct Pharma AB, Intervacc AB (publ), Enzymatica AB (publ), Iconovo AB (publ), Alzinova AB (publ) and Swedish Orphan Biovitrum AB (publ).